Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Pike (1973)
The Analysis of Clinical Trials in LeukaemiaRecent results in cancer research, 43
R. Heyn, P. Joo, M. Karon, M. Nesbit, N. Shore, N. Breslow, J. Weiner, A. Reed, D. Hammond (1975)
BCG in the treatment of acute lymphocytic leukemia.Blood, 46 3
R. Peto, M. Pike (1973)
Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.Biometrics, 29 3
D. Cox (1972)
Regression models and life tables (with discussion
M. Zelen (1973)
Keynote address on biostatistics and data retrieval.Cancer chemotherapy reports. Part 3, 4 2
(1971)
MEDICAL RESEARCH COUNSCIL (1971b) Treatment
(1973)
Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.British journal of haematology, 24 1
R. Peto (1972)
Asymptotically efficient rank invariant test procedure (with discussion)., 135
(1976)
Digoxin does not Prevent Daunorubicin or Adramycin from Binding to Rat Heart Muscle
N. Breslow (1975)
Analysis of Survival Data under the Proportional Hazards ModelInternational Statistical Review, 43
N. Mantel (1966)
Evaluation of survival data and two new rank order statistics arising in its consideration.Cancer chemotherapy reports, 50 3
G. Mathé, J. Amiel, L. Schwarzenberg, M. Schneider, A. Cattan, J. Schlumberger, M. Hayat, F. Vassal (1969)
Active immunotherapy for acute lymphoblastic leukaemia.Lancet, 1 7597
P. Armitage, E. Gehan (1974)
Statistical methods for the identification and use of prognostic factorsInternational Journal of Cancer, 13
L. Sinks (1972)
Treatment of acute lymphoblastic leukaemia.Archives of Disease in Childhood, 47
E. Gehan (1965)
A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.Biometrika, 52
(1972)
Rank Tests of Maximal Power a t Lehmann-type Alternatives
(1972)
Influence of Pharmacolsinetic Variations on the Pharmacological Properties of Adramycin. International Symposium on Adramycin
E. Kaplan, P. Meier (1958)
Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 53
(1971)
Myelomatosis: Comparison of Melphalan and Cyclophosphamide TherapyBritish Medical Journal, 1
Acute Myeloid Leukaemia with Daunorubicin, Cytosine Arabinoside, Mercaptopurine, L-asparaginase, Prednisone and Thioguanine: Results of Treatment with Five Multi-drug Schedules
Part I of this report appeared in the previous issue (Br. J. Cancer (1976) 34,585), and discussed the design of randomized clinical trials. Part II now describes efficient methods of analysis of randomized clinical trials in which we wish to compare the duration of survival (or the time until some other untoward event first occurs) among different groups of patients. It is intended to enable physicians without statistical training either to analyse such data themselves using life tables, the logrank test and retrospective stratification, or, when such analyses are presented, to appreciate them more critically, but the discussion may also be of interest to statisticians who have not yet specialized in clinical trial analyses.
British Journal of Cancer – Springer Journals
Published: Jan 1, 1977
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.